Kyverna Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.82-$13.67 |
Market Cap | $573.7M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$133.7M |
Diluted EPS | -$3.64 |
News
See moreYahoo Finance • 6 days ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Yahoo Finance • 10 days ago
The Oncology Institute Names Minh Merchant Chief Legal Officer
Yahoo Finance • last month
Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026
Yahoo Finance • 4 months ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
About
CEO | Mr. Warner Biddle |
Address | 5980 Horton Street, Emeryville, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
